Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Serious Illness Treatment Preferences for Older Adults with Advanced CKD.

Baddour NA, Siew ED, Robinson-Cohen C, Salat H, Mason OJ, Stewart TG, Karlekar M, El-Sourady MH, Lipworth L, Abdel-Kader K.

J Am Soc Nephrol. 2019 Sep 11. pii: ASN.2019040385. doi: 10.1681/ASN.2019040385. [Epub ahead of print]

PMID:
31511360
2.

The association of exercise and sedentary behaviours with incident end-stage renal disease: the Southern Community Cohort Study.

Pike M, Taylor J, Kabagambe E, Stewart TG, Robinson-Cohen C, Morse J, Akwo E, Abdel-Kader K, Siew ED, Blot WJ, Ikizler TA, Lipworth L.

BMJ Open. 2019 Aug 30;9(8):e030661. doi: 10.1136/bmjopen-2019-030661.

3.

Racial disparities in end-stage renal disease in a high-risk population: the Southern Community Cohort Study.

Bock F, Stewart TG, Robinson-Cohen C, Morse J, Kabagambe EK, Cavanaugh KL, Birdwell KA, Hung AM, Abdel-Kader K, Siew ED, Akwo EA, Blot WJ, Ikizler TA, Lipworth L.

BMC Nephrol. 2019 Aug 7;20(1):308. doi: 10.1186/s12882-019-1502-z.

4.

Hernia recurrence inventory: inguinal hernia recurrence can be accurately assessed using patient-reported outcomes.

Tastaldi L, Barros PHF, Krpata DM, Prabhu AS, Rosenblatt S, Petro CC, Alkhatib H, Szutan LA, Silva RA, Olson MA, Stewart TG, Roll S, Rosen MJ, Poulose BK.

Hernia. 2019 Jul 29. doi: 10.1007/s10029-019-02000-z. [Epub ahead of print]

PMID:
31359209
5.

Comparing pathologic outcomes for robotic versus laparoscopic Surgery in rectal cancer resection: a propensity adjusted analysis of 7616 patients.

Hopkins MB, Geiger TM, Bethurum AJ, Ford MM, Muldoon RL, Beck DE, Stewart TG, Hawkins AT.

Surg Endosc. 2019 Jul 25. doi: 10.1007/s00464-019-07032-1. [Epub ahead of print]

PMID:
31346754
6.

APOL1, Acid Load, and CKD Progression.

Pike M, Stewart TG, Morse J, Ormsby P, Siew ED, Hung A, Abdel-Kader K, Ikizler TA, Lipworth L, Robinson-Cohen C.

Kidney Int Rep. 2019 Apr 4;4(7):946-954. doi: 10.1016/j.ekir.2019.03.022. eCollection 2019 Jul.

7.

The Surprise Question and Self-Rated Health Are Useful Screens for Frailty and Disability in Older Adults with Chronic Kidney Disease.

Baddour NA, Robinson-Cohen C, Lipworth L, Bian A, Stewart TG, Jhamb M, Siew ED, Abdel-Kader K.

J Palliat Med. 2019 Jun 28. doi: 10.1089/jpm.2019.0054. [Epub ahead of print]

PMID:
31259659
8.

Development and Validation of the Ventral Hernia Repair Outcomes Reporting App for Clinician and Patient Engagement (ORACLE).

Haskins IN, Olson MA, Stewart TG, Rosen MJ, Poulose BK.

J Am Coll Surg. 2019 Sep;229(3):259-266. doi: 10.1016/j.jamcollsurg.2019.03.014. Epub 2019 May 2.

PMID:
31054912
9.

The effect of increasing body mass index on wound complications in open ventral hernia repair with mesh.

Tastaldi L, Krpata DM, Prabhu AS, Petro CC, Rosenblatt S, Haskins IN, Olson MA, Stewart TG, Rosen MJ, Greenberg JA.

Am J Surg. 2019 Sep;218(3):560-566. doi: 10.1016/j.amjsurg.2019.01.022. Epub 2019 Jan 25.

PMID:
30722933
10.

Health Outcome Priorities of Older Adults with Advanced CKD and Concordance with Their Nephrology Providers' Perceptions.

Ramer SJ, McCall NN, Robinson-Cohen C, Siew ED, Salat H, Bian A, Stewart TG, El-Sourady MH, Karlekar M, Lipworth L, Ikizler TA, Abdel-Kader K.

J Am Soc Nephrol. 2018 Dec;29(12):2870-2878. doi: 10.1681/ASN.2018060657. Epub 2018 Nov 1.

PMID:
30385652
11.

Factors associated with recurrence and mortality in central line-associated bloodstream infections: a retrospective cohort study.

Huerta LE, Nelson GE, Stewart TG, Rice TW.

Crit Care. 2018 Oct 26;22(1):266. doi: 10.1186/s13054-018-2206-7.

12.

Insulin resistance is a significant determinant of sarcopenia in advanced kidney disease.

Deger SM, Hewlett JR, Gamboa J, Ellis CD, Hung AM, Siew ED, Mamnungu C, Sha F, Bian A, Stewart TG, Abumrad NN, Ikizler TA.

Am J Physiol Endocrinol Metab. 2018 Dec 1;315(6):E1108-E1120. doi: 10.1152/ajpendo.00070.2018. Epub 2018 Jun 12.

PMID:
29894202
13.

Systemic inflammation is associated with exaggerated skeletal muscle protein catabolism in maintenance hemodialysis patients.

Deger SM, Hung AM, Gamboa JL, Siew ED, Ellis CD, Booker C, Sha F, Li H, Bian A, Stewart TG, Zent R, Mitch WE, Abumrad NN, Ikizler TA.

JCI Insight. 2017 Nov 16;2(22). pii: 95185. doi: 10.1172/jci.insight.95185. eCollection 2017 Nov 16.

14.

Metabolic Effects of Diet and Exercise in Patients with Moderate to Severe CKD: A Randomized Clinical Trial.

Ikizler TA, Robinson-Cohen C, Ellis C, Headley SAE, Tuttle K, Wood RJ, Evans EE, Milch CM, Moody KA, Germain M, Limkunakul C, Bian A, Stewart TG, Himmelfarb J.

J Am Soc Nephrol. 2018 Jan;29(1):250-259. doi: 10.1681/ASN.2017010020. Epub 2017 Oct 16.

15.

Nephrology Provider Prognostic Perceptions and Care Delivered to Older Adults with Advanced Kidney Disease.

Salat H, Javier A, Siew ED, Figueroa R, Lipworth L, Kabagambe E, Bian A, Stewart TG, El-Sourady MH, Karlekar M, Cardona CY, Ikizler TA, Abdel-Kader K.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1762-1770. doi: 10.2215/CJN.03830417. Epub 2017 Sep 18.

16.

Reliability and Utility of the Surprise Question in CKD Stages 4 to 5.

Javier AD, Figueroa R, Siew ED, Salat H, Morse J, Stewart TG, Malhotra R, Jhamb M, Schell JO, Cardona CY, Maxwell CA, Ikizler TA, Abdel-Kader K.

Am J Kidney Dis. 2017 Jul;70(1):93-101. doi: 10.1053/j.ajkd.2016.11.025. Epub 2017 Feb 15.

17.

Tissue sodium accumulation and peripheral insulin sensitivity in maintenance hemodialysis patients.

Deger SM, Wang P, Fissell R, Ellis CD, Booker C, Sha F, Morse JL, Stewart TG, Gore JC, Siew ED, Titze J, Ikizler TA.

J Cachexia Sarcopenia Muscle. 2017 Jun;8(3):500-507. doi: 10.1002/jcsm.12179. Epub 2017 Feb 1.

18.

High prevalence of non-steroidal anti-inflammatory drug use among acute kidney injury survivors in the southern community cohort study.

Lipworth L, Abdel-Kader K, Morse J, Stewart TG, Kabagambe EK, Parr SK, Birdwell KA, Matheny ME, Hung AM, Blot WJ, Ikizler TA, Siew ED.

BMC Nephrol. 2016 Nov 24;17(1):189.

19.

Sarcopenic Obesity Definitions by Body Composition and Mortality in the Hemodialysis Patients.

Malhotra R, Deger SM, Salat H, Bian A, Stewart TG, Booker C, Vincz A, Pouliot B, Ikizler TA.

J Ren Nutr. 2017 Mar;27(2):84-90. doi: 10.1053/j.jrn.2016.09.010. Epub 2016 Nov 19.

20.

Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network.

Brown RS Jr, O'Leary JG, Reddy KR, Kuo A, Morelli GJ, Burton JR Jr, Stravitz RT, Durand C, Di Bisceglie AM, Kwo P, Frenette CT, Stewart TG, Nelson DR, Fried MW, Terrault NA; Hepatitis C Therapeutic Registry Research Network Study Group.

Liver Transpl. 2016 Jan;22(1):24-33. doi: 10.1002/lt.24366.

21.

Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection.

Sulkowski MS, Vargas HE, Di Bisceglie AM, Kuo A, Reddy KR, Lim JK, Morelli G, Darling JM, Feld JJ, Brown RS, Frazier LM, Stewart TG, Fried MW, Nelson DR, Jacobson IM; HCV-TARGET Study Group.

Gastroenterology. 2016 Feb;150(2):419-29. doi: 10.1053/j.gastro.2015.10.013. Epub 2015 Oct 21.

22.

An exploratory analysis of the relationship between ambient ozone and particulate matter concentrations during early pregnancy and selected birth defects in Texas.

Vinikoor-Imler LC, Stewart TG, Luben TJ, Davis JA, Langlois PH.

Environ Pollut. 2015 Jul;202:1-6. doi: 10.1016/j.envpol.2015.03.001. Epub 2015 Mar 14.

PMID:
25782177
23.

Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir.

Sterling RK, Kuo A, Rustgi VK, Sulkowski MS, Stewart TG, Fenkel JM, El-Genaidi H, Mah'moud MA, Abraham GM, Stewart PW, Akushevich L, Nelson DR, Fried MW, Di Bisceglie AM.

Aliment Pharmacol Ther. 2015 Apr;41(7):671-85. doi: 10.1111/apt.13095. Epub 2015 Jan 28.

24.

Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET.

Gordon SC, Muir AJ, Lim JK, Pearlman B, Argo CK, Ramani A, Maliakkal B, Alam I, Stewart TG, Vainorius M, Peter J, Nelson DR, Fried MW, Reddy KR; HCV-TARGET study group.

J Hepatol. 2015 Feb;62(2):286-93. doi: 10.1016/j.jhep.2014.08.052. Epub 2014 Sep 10.

25.

The LKB1 tumor suppressor as a biomarker in mouse and human tissues.

Nakada Y, Stewart TG, Peña CG, Zhang S, Zhao N, Bardeesy N, Sharpless NE, Wong KK, Hayes DN, Castrillon DH.

PLoS One. 2013 Sep 25;8(9):e73449. doi: 10.1371/journal.pone.0073449. eCollection 2013.

26.

Synthesis of several mesoionic 1,3,4-thiadiazoles.

Stewart TG, Kier LB.

J Pharm Sci. 1965 May;54(5):731-4. No abstract available.

PMID:
4378942
27.

A NEW CLASS OF ANTIMICROBIAL AGENTS.

KIER LB, DODD MC, SAPKO P, STEWART TG.

Nature. 1964 Nov 14;204:697. No abstract available.

PMID:
14236303
28.

Myopathy with Fibrillation.

Stewart TG.

Proc R Soc Med. 1928 Feb;21(4):552. No abstract available.

29.

DISCUSSION ON EPILEPSY.

Stewart TG.

Proc R Soc Med. 1927 Apr;20(6):865. No abstract available.

30.

Case of Obesity? Pituitary in Origin.

Stewart TG.

Proc R Soc Med. 1926;19(Sect Study Dis Child):41-2. No abstract available.

31.

Case of Syphilitic Amyotrophy (? Congenital Lues).

Stewart TG.

Proc R Soc Med. 1924;17(Neurol Sect):54. No abstract available.

32.

Case of Sclerodermia.

Stewart TG.

Proc R Soc Med. 1923;16(Neurol Sect):31-2. No abstract available.

33.
34.
35.

Pituitary Tumour; Symptoms of Failure of Posterior Lobe Function.

Stewart TG, Brewerton E.

Proc R Soc Med. 1913;6(Neurol Sect):xxiii-xxiv. No abstract available.

36.

Pituitary Tumour.

Stewart TG, Parsons H.

Proc R Soc Med. 1913;6(Neurol Sect):xx-xxii. No abstract available.

37.

Bilateral Involuntary Movements, Athetoid and Choreiform.

Stewart TG.

Proc R Soc Med. 1912;5(Neurol Sect):62-7. No abstract available.

38.

Pseudo-bulbar Paralysis of Doubtful Origin, probably Disseminated Sclerosis.

Stewart TG.

Proc R Soc Med. 1911;4(Neurol Sect):46-8. No abstract available.

39.

Pseudo-bulbar Paralysis of Doubtful Origin.

Stewart TG.

Proc R Soc Med. 1911;4(Neurol Sect):23-5. No abstract available.

40.

Chronic Syphilitic Meningitis with Compression of the Cord.

Stewart TG.

Proc R Soc Med. 1910;3(Neurol Sect):33. No abstract available.

41.

Compression Paraplegia: Syphilitic Meningitis.

Stewart TG.

Proc R Soc Med. 1910;3(Neurol Sect):20-3. No abstract available.

42.
43.

Facial Paralysis resulting from Herpes of the Upper Cervical and Geniculate Ganglia.

Stewart TG.

Proc R Soc Med. 1909;2(Neurol Sect):111. No abstract available.

44.

Combined Tabes and Paralysis Agitans.

Stewart TG.

Proc R Soc Med. 1909;2(Neurol Sect):109-11. No abstract available.

45.

Compression Paraplegia.

Stewart TG.

Proc R Soc Med. 1909;2(Neurol Sect):104-5. No abstract available.

46.

A Note upon the Symptomatology of Tumours growing in the Fourth Ventricle.

Stewart TG.

Proc R Soc Med. 1908;1(Neurol Sect):26-38. No abstract available.

49.

Address in Medicine.

Stewart TG.

Br Med J. 1894 Aug 4;2(1753):242-9. No abstract available.

Supplemental Content

Loading ...
Support Center